Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03979885

Financial Incentives for Smoking Treatment II

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Smoking Cessation Behavior Health Behavior Tobacco Use Cessation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

David Geffen School of Medicine, Los Angeles, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age ≥ 18 years
  • smoked tobacco during the prior 30 days,
  • have an active U.S. phone number and address,
  • can provide consent in English or Spanish and
  • are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit

Exclusion criteria

  • use only smokeless tobacco,
  • are pregnant or breastfeeding,
  • are discharged to an institution (e.g., nursing home, long-term care facility),
  • are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study

Treatment and study plan

Smoking cessation counseling (Quitline)

Behavioral

Quitline offers community-based counseling session with a cessation counselor.

Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)

Behavioral

Participants will be encouraged to speak to their doctors about using highly effective pharmacotherapies for smoking cessation.

Financial incentives for smoking cessation

Behavioral

Participants will receive financial incentives for bioconfirmed smoking cessation.

Financial incentives for use of evidence-based smoking cessation therapies

Behavioral

Participants will receive financial incentives for the use of evidence-based smoking cessation therapies including Quitline counseling, community-based smoking cessation programs and pharmacotherapies

Primary outcomes

  1. Smoking abstinence assessed by self-report and biochemically verified by salivary cotinine

    Time frame: 6 months

    Assessed by self-report questionnaire, and biochemically verified by salivary cotinine

Secondary outcomes

  1. Use of evidence based treatment (e.g. counseling and smoking cessation medications) assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report

    Time frame: 2 months

    Assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report

  2. Quality of life as measured by PROMIS-29 Profile v2.0

    Time frame: 12 months

    Assessed by phone interviews.

  3. Short term return on investment of using financial incentives to promote smoking cessation (Cost analysis)

    Time frame: 12 months

    Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization

  4. Long term return on investment of using financial incentives to promote smoking cessation (Cost analysis)

    Time frame: 3 years

    Cost analysis involving hospital utilization data, electronic health records and patient-reported healthcare utilization

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Collaborators

  • NYU Langone Health
  • Olive View-UCLA Education & Research Institute

Registry information

Official study title

Financial Incentives for Smoking Treatment

Acronym: FIESTA II

Important dates

Study start
2020
Primary completion
2025
Study completion
2027
First posted
Jun 7, 2019
Registry last updated
Apr 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.